Saturday, September 12, 2020 5:57:38 PM
Penny. Believe the inhaler trial is the P2b/3 trial and may or may not be recruiting yet. Looking at the clinical trials update they haven't stated active and recruiting ...probably needed the $ they recently received.
The IV trial is a P 2.... but supported by the compassionate use data ...may / will be enough for approval for wider use if the data is as good as we hope .
Just my take
Kiwi
The IV trial is a P 2.... but supported by the compassionate use data ...may / will be enough for approval for wider use if the data is as good as we hope .
Just my take
Kiwi
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
